Severe Acute Respiratory Syndrome Spike (CT) Blocking Peptide

Antibody Details

Product Details

Reactivity Species

Virus

Product Concentration

0.2 mg/ml

Amino Acid Location

20 Amino acids near the C-terminus of SARS Spike protein.

Formulation

This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.

Storage and Handling

Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Country of Origin

USA

Shipping

Next Day Ambient

Amino Acid Sequence

20 amino acids near the carboxy terminus of SARS Spike protein.

Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background

Severe Acute Respiratory Syndrome Spike Protein peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

Protein

SARS Spike

PubMed

SARS Spike

References & Citations

1. Edwards SW, Derouet M, Howse M, et al. Regulation of neutrophil apoptosis by Mcl-1. Biochem Soc Trans. 2004; 32:489-92.

2. Cuconati A, Mukherjee C, Perez D, et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes and Dev. 2003; 17:2922-32.

3. Opferman JT, Letai A, Beard C, et al. Development and maintenance of B and T lymphocytes require antiapoptotic MCL-1. Nature 2003; 426:671-6.

4. Kozopas KM, Yang T, Buchan HL, et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 1993; 90:3516-20.